Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
HROW
HROW
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
HROW News
OSRX Continues Support for California Ophthalmologists After Competitor's Exit
Feb 03 2026
Newsfilter
OSRX Continues Support in California Market After Competitor Exit
Feb 03 2026
Yahoo Finance
Okta Inc (OKTA) Options Volume Hits 13,284 Contracts, 52.9% of Average Daily Volume
Jan 16 2026
NASDAQ.COM
Antero Resources Sees 31,767 Options Contracts Trading, 64.9% of Average Volume
Jan 05 2026
NASDAQ.COM
Significant Friday Options Trading: HROW, EWTX, RBLX
Dec 12 2025
NASDAQ.COM
Harrow to Participate in Two Investor Conferences Focused on Ophthalmic Management
Nov 24 2025
Newsfilter
HC Wainwright & Co. Reaffirms Buy Rating on Harrow, Increases Price Target to $69
Nov 12 2025
Benzinga
Harrow Revises 2025 Revenue Forecast to $270M–$280M, Fueled by VEVYE and IHEEZO's Significant Coverage Success
Nov 11 2025
SeekingAlpha
Outset Medical, Gemini Space Station, CoreWeave, and Other Major Stocks Decline in Tuesday's Pre-Market Trading
Nov 11 2025
Benzinga
Significant Options Activity on Monday: COGT, PGY, HROW
Nov 10 2025
NASDAQ.COM
Harrow Health Reports Non-GAAP EPS of $0.33, Exceeding Estimates by $0.04; Revenue of $71.6M Falls Short by $2.1M
Nov 10 2025
SeekingAlpha
Harrow Health Q3 2025 Earnings Forecast
Nov 07 2025
SeekingAlpha
Significant Options Trading on Wednesday: HROW, WAY, ATR
Oct 29 2025
NASDAQ.COM
Significant Monday Options Trading: SANM, HROW, ASPN
Oct 06 2025
NASDAQ.COM
Lake Street Reiterates Buy Rating on Harrow, Increases Price Target to $70
Sep 29 2025
Benzinga
HC Wainwright & Co. Affirms Buy Rating for Harrow, Keeps Price Target at $64
Sep 29 2025
Benzinga
Show More News
